Medicines in pregnancy—women and children first? Time for a coalition to address a substantial patient need
L Dewulf - Therapeutic Innovation & Regulatory Science, 2013 - journals.sagepub.com
Medical care during and around pregnancy needs better data. Pre-existing medical
conditions (25% and increasing) and intercurrent illnesses cause an estimated 90% of …
conditions (25% and increasing) and intercurrent illnesses cause an estimated 90% of …
Pharmacotherapy and pregnancy: highlights from the third international conference for individualized pharmacotherapy in pregnancy
DM Haas, B Gallauresi, K Shields… - Clinical and …, 2011 - Wiley Online Library
To address provider struggles to provide evidence‐based, rational drug therapy to pregnant
women, this third Conference was convened to highlight the current progress and research …
women, this third Conference was convened to highlight the current progress and research …
Collaboration in regulatory science to facilitate therapeutic development for pregnant women
C Roca, L Sahin, L Yao - Current Pharmaceutical Design, 2019 - ingentaconnect.com
Background: Therapeutic tragedies of the past, ethical concerns, and legal risks, among
other factors have led to a conservative approach to clinical research during pregnancy …
other factors have led to a conservative approach to clinical research during pregnancy …
[HTML][HTML] Pharmacotherapy and pregnancy: highlights from the First International Conference for Individualized Pharmacotherapy in Pregnancy
DM Haas, JL Renbarger, S Denne… - Clinical and …, 2009 - ncbi.nlm.nih.gov
Half of the world's population is women. The majority of women become pregnant, and many
of those women take some kind of medication during their pregnancy, even if only for a short …
of those women take some kind of medication during their pregnancy, even if only for a short …
[PDF][PDF] Safe and effective medicines for use in pregnancy: a call to action
S Bhattacharya - … Health Partners Centre for Regulatory Science …, 2021 - birmingham.ac.uk
Safe and Effective Medicines for Use in Pregnancy: A Call to Action Page 1 Safe and Effective
Medicines for Use in Pregnancy: A Call to Action By Shaoni Bhattacharya, on behalf of the …
Medicines for Use in Pregnancy: A Call to Action By Shaoni Bhattacharya, on behalf of the …
[HTML][HTML] Pharmacologic research in pregnant women—time to get it right
Approximately 6 million women in the United States become pregnant every year, and 4
million of them will have a live birth. Many pregnant women (70 to 80%) take at least one …
million of them will have a live birth. Many pregnant women (70 to 80%) take at least one …
[PDF][PDF] Improving knowledge on safety is key to enabling drug access for pregnant and breastfeeding women
LC Chappell, S Tong - Clinical Pharmacology & …, 2021 - minerva-access.unimelb.edu.au
If pregnant women were an ethnic minority group, or perhaps elderly citizens, imagine the
indignation if they were systematically excluded from clinical trials, research, and new …
indignation if they were systematically excluded from clinical trials, research, and new …
Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy–call for action
K Van Calsteren, K Gersak, H Sundseth… - European Journal of …, 2016 - Elsevier
Less than 10% of medicines approved by the FDA since 1980 have provided enough
information as regards risks for birth defects associated with their use (Adam et al.(2011)[1]) …
information as regards risks for birth defects associated with their use (Adam et al.(2011)[1]) …
Drug-prescribing challenges during pregnancy
AM Freyer - Obstetrics, Gynaecology & Reproductive Medicine, 2008 - Elsevier
Most women take either prescribed or over-the-counter medication during pregnancy.
Pregnant women often make independent decisions about their treatment and require …
Pregnant women often make independent decisions about their treatment and require …